Stockreport

Bristol-Myers Squibb Co (BMY) Reports Solid Q4 and Full-Year 2023 Results; Plans for Future Growth [Yahoo! Finance]

Karuna Therapeutics, Inc.  (KRTX) 
PDF GAAP EPS : Q4 at $0.87, Full-Year at $3.86, reflecting a 31% increase for the full year. Non-GAAP EPS : Q4 at $1.70, Full-Year at $7.51, indicating resilience in adju [Read more]